MicroRNA-126 and micro-/macrovascular complications of type 1 diabetes in the EURODIAB Prospective Complications Study

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Acta Diabetologica

• Publication date

  2017-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00592-016-0915-4PMID 27696070
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus

  2016cited by this paper
• Noncoding RNAs in diabetes vascular complications.

  2015cited by this paper
• The Role of microRNA-126 in Vascular Homeostasis.

  2015cited by this paper
• Circulating TGF-β1–Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes

  2015cited by this paper
• MicroRNAs in platelet function and cardiovascular disease

  2015cited by this paper
• Angiogenic microRNAs Linked to Incidence and Progression of Diabetic Retinopathy in Type 1 Diabetes

  2015cited by this paper
• β-Cell MicroRNAs: Small but Powerful

  2015cited by this paper
• Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A

  2014cited by this paper
• Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy

  2013cited by this paper
• Hypoxia-Induced Deregulation of miR-126 and Its Regulative Effect on VEGF and MMP-9 Expression

  2013cited by this paper
• Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis

  2013cited by this paper
• The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding.

  2013cited by this paper
• Plasma miR-126 Is a Potential Biomarker for Early Prediction of Type 2 Diabetes Mellitus in Susceptible Individuals

  2013cited by this paper
• Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.

  2013cited by this paper
• Abstract 10882: Endothelial Microparticle-mediated Transfer of MicroRNA-126 Promotes Vascular Endothelial Cell Repair Via SPRED1 and is Abrogated in Glucose-damaged Endothelial Microparticles

  2013cited by this paper
• MicroRNA-126 contributes to renal microvascular heterogeneity of VCAM-1 protein expression in acute inflammation.

  2012cited by this paper
• MicroRNA-15a and MicroRNA-16 Impair Human Circulating Proangiogenic Cell Functions and Are Increased in the Proangiogenic Cells and Serum of Patients With Critical Limb Ischemia

  2012cited by this paper
• Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression

  2012cited by this paper
• MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival

  2011cited by this paper
• MicroRNA-126 modulates endothelial SDF-1 expression and mobilization of Sca-1(+)/Lin(-) progenitor cells in ischaemia.

  2011cited by this paper
• Role of microRNAs in diabetes and its cardiovascular complications

  2011cited by this paper
• Circulating MicroRNAs in cardiovascular disease.

  2011cited by this paper
• Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes

  2010cited by this paper
• Circulating MicroRNAs in Patients With Coronary Artery Disease

  2010cited by this paper
• Anti–Heat Shock Protein 27 Antibody Levels and Diabetes Complications in the EURODIAB Study

  2009cited by this paper
• Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients

  2009cited by this paper
• Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury.

  2009cited by this paper
• ANTI‐HSP60 and ANTI‐HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study

  2009cited by this paper
• SERUM HSP27 AND DIABETIC COMPLICATIONS IN THE EURODIAB PROSPECTIVE COMPLICATIONS STUDY: A NOVEL CIRCULATING MARKER FOR DIABETIC NEUROPATHY

  2008cited by this paper
• Serum Heat Shock Protein 27 and Diabetes Complications in the EURODIAB Prospective Complications Study

  2008cited by this paper
• MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1

  2008cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• The Human Angiotensin II Type 1 Receptor +1166 A/C Polymorphism Attenuates MicroRNA-155 Binding*

  2007cited by this paper
• Incidence and Risk Factors of Prolonged QTc Interval in Type 1 Diabetes

  2007cited by this paper
• MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts.

  2006cited by this paper
• MicroRNA-155 Regulates Human Angiotensin II Type 1 Receptor Expression in Fibroblasts*

  2006cited by this paper
• SDF-1 is both necessary and sufficient to promote proliferative retinopathy.

  2005cited by this paper
• Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes—the EURODIAB Prospective Complications Study

  2005cited by this paper
• MicroRNAs: small RNAs with a big role in gene regulation

  2004cited by this paper
• Circulating and urinary transforming growth factor beta1, Amadori albumin, and complications of type 1 diabetes: the EURODIAB prospective complications study.

  2002cited by this paper
• Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes.

  2001cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study

  1994cited by this paper

• Diyabet ve Kanser Biyobelirteçleri: Hücre Dışı DNA ve RNA

  2026cites this paper
• MicroRNAs in type 2 diabetes mellitus and its cardiovascular complications: mechanistic insights and translational potential.

  2026cites this paper
• Exploring the role of miR-126 in diabetes and its complications: a comprehensive review

  2025cites this paper
• Emerging Biomarkers and Nanobiosensing Strategies in Diabetes

  2025cites this paper
• Potential diagnostic value of microRNAs in vascular complications of diabetes: A systematic review and meta-analysis

  2025cites this paper
• Sleep and Sugar: Deciphering the 2003–2023 Research Landscape on Sleep Disorders and Diabetes Mellitus via Bibliometric Study

  2025cites this paper
• The inflammatory-miRNA axis in diabetic microvascular complications: a meta-analysis highlighting synergistic effects in concurrent retinopathy and nephropathy

  2025cites this paper
• Precision Medicine in Diabetic Retinopathy: The Role of Genetic and Epigenetic Biomarkers

  2025cites this paper
• Circulating non-coding RNA in type 1 diabetes mellitus as a source of potential biomarkers - An emerging role of sex difference.

  2024cites this paper
• A novel microRNA promotes coxsackievirus B4 infection of pancreatic β cells

  2024cites this paper
• Insights into the Novel Biomarkers Expressed in Diabetic Nephropathy: Potential Clinical Applications.

  2024cites this paper
• Importance of Studying Non-Coding RNA in Children and Adolescents with Type 1 Diabetes

  2024cites this paper
• Analysis of Circulating miRNA Expression Profiles in Type 2 Diabetes Patients with Diabetic Foot Complications

  2024cites this paper
• Pediatric Diabetic Nephropathy: Novel Insights from microRNAs

  2023cites this paper
• Exploring the theranostic potentials of miRNA and epigenetic networks in autoimmune diseases: A comprehensive review

  2023cites this paper
• Predicting diagnostic gene biomarkers in patients with diabetic kidney disease based on weighted gene co expression network analysis and machine learning algorithms

  2023cites this paper
• Serum microRNA-126 expression as a biomarker of diabetic retinopathy

  2023cites this paper
• Serum MicroRNA-191-5p Levels in Vascular Complications of Type 1 Diabetes: The EURODIAB Prospective Complications Study

  2023cites this paper
• Cardiac angiogenesis enhances by activating Mir-126 and related target proteins in type 2 diabetic rats: Rescue combination effect of Sodium butyrate and voluntary exercise therapy

  2023cites this paper
• Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective.

  2023cites this paper
• The Dynamics and Plasticity of Epigenetics in Diabetic Kidney Disease: Therapeutic Applications Vis-à-Vis

  2022cites this paper
• MiRNA-200b level in peripheral blood predicts renal interstitial injury in patients with diabetic nephropathy

  2022cites this paper
• Extracellular vesicles metabolic changes reveals plasma signature in stage-dependent diabetic kidney disease

  2022cites this paper
• Current Insights into miRNA and lncRNA Dysregulation in Diabetes: Signal Transduction, Clinical Trials and Biomarker Discovery

  2022influential citation
• MicroRNA-150 (miR-150) and Diabetic Retinopathy: Is miR-150 Only a Biomarker or Does It Contribute to Disease Progression?

  2022influential citation
• Diabetic kidney disease treatment: new perspectives

  2022cites this paper
• Novel biomarkers for diabetic kidney disease

  2022cites this paper
• The role of microRNA-126 in atherosclerotic cardiovascular diseases.

  2022cites this paper
• Type 1 Diabetes Mellitus-Related circRNAs Regulate CD4+ T Cell Functions

  2022cites this paper
• Clinical application of microRNAs in glomerular diseases.

  2022cites this paper
• Association of Serum MicroRNA-145-5p Levels with Microvascular Complications of Type 1 Diabetes: the EURODIAB Prospective Complications Study.

  2022cites this paper
• Novel Markers in Diabetic Kidney Disease—Current State and Perspectives

  2022cites this paper
• Decreased Levels of miR-126 and miR-132 in Plasma and Vitreous Humor of Non-Proliferative Diabetic Retinopathy Among Subjects with Type-2 Diabetes Mellitus

  2022cites this paper
• Circulatory miR-126 expression as an epigenetic marker in diabetes mellitus; a systematic review & meta-analysis

  2022cites this paper
• Correlation between Highly Sensitive C Reactive Protein and Development of Microvascular Complications of Type 2 Diabetes Mellitus

  2022cites this paper
• Vitreous microparticles contain apoptotic signals suggesting a diabetic vitreopathy.

  2022cites this paper
• Non-Coding RNA and Diabetic Kidney Disease

  2021cites this paper
• Clinical significance of serum miR-129-5p in patients with diabetes mellitus presenting macrovascular complications

  2021cites this paper
• Genetic Indices Relationship to Hyperglycemia-associated Biomarkers: Consistency with miRNA Expression in Egyptian Children with T1DM

  2021cites this paper
• MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS

  2021cites this paper
• Epigenetic Mechanisms in Type 2 Diabetes Retinopathy: A Systematic Review

  2021influential citation
• Mean Platelet Volume and Platelet Distribution Width Correlate with Microvascular Complications in Egyptian People with Type 2 Diabetes Mellitus.

  2021cites this paper
• MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus)

  2021cites this paper
• Type 1 Diabetes and Associated Cardiovascular Damage: Contribution of Extracellular Vesicles in Tissue Crosstalk

  2021cites this paper
• Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes

  2021cites this paper
• Involvement of miR‐126 rs4636297 and miR‐146a rs2910164 polymorphisms in the susceptibility for diabetic retinopathy: a case–control study in a type 1 diabetes population

  2020cites this paper
• MiR-126 targets IL-17A to enhance proliferation and inhibit apoptosis in high-glucose-induced human retinal endothelial cells.

  2020cites this paper
• Blood Co-Circulating Extracellular microRNAs and Immune Cell Subsets Associate with Type 1 Diabetes Severity

  2020cites this paper
• MicroRNAs in Vascular Eye Diseases

  2020cites this paper
• microRNA Expression Profiling Based on Microarray Approach in Human Diabetic Retinopathy: A Systematic Review and Meta-Analysis

  2020cites this paper
• Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets

  2020cites this paper
• MicroRNA-1281 as a Novel Circulating Biomarker in Patients With Diabetic Retinopathy

  2020cites this paper
• Progression of Diabetic Complications in Subgroups of People with Long Term Diabetes Type 1 According to Clinical Course

  2020cites this paper
• Endothelial Dysfunction in Diabetic Retinopathy

  2020cites this paper
• MicroRNA and vascular pathology of the eye

  2020cites this paper
• Exosomes from microRNA‐126 overexpressing mesenchymal stem cells promote angiogenesis by targeting the PIK3R2‐mediated PI3K/Akt signalling pathway

  2020cites this paper
• Efficacy of metformin combined with insulin lispro on gestational diabetes and effects on serum miR-16

  2020cites this paper
• The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it

  2019cites this paper
• MicroRNAs in the Progress of Diabetic Nephropathy: A Systematic Review and Meta-Analysis

  2019cites this paper
• Omics-based biomarkers in the diagnosis of diabetes

  2019cites this paper
• MicroRNAs: new biomarkers and promising therapeutic targets for diabetic kidney disease

  2019cites this paper
• The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy

  2019cites this paper
• DMSO_A_199705 1685..1696

  2019cites this paper
• MicroRNA-126: a promising biomarker for angiogenesis of diabetic wounds treated with negative pressure wound therapy

  2019cites this paper
• MicroRNA-Related Genetic Variants Are Associated With Diabetic Retinopathy in Type 1 Diabetes Mellitus.

  2019cites this paper
• GALLIC ACID IMPROVES OXIDATIVE STRESS AND INFLAMMATION THROUGH REGULATING MICRORNAS EXPRESSIONS IN THE BLOOD OF DIABETIC RATS.

  2019cites this paper
• The circulating exosomal microRNAs related to albuminuria in patients with diabetic nephropathy

  2019cites this paper
• Micro-RNAs 518d-3p and 618 Are Upregulated in Individuals With Type 1 Diabetes With Multiple Microvascular Complications

  2019cites this paper
• The low expression of circulating microRNA-19a represents an additional mortality risk in stable patients with vascular disease.

  2019cites this paper
• Glucose impairs angiogenesis and promotes ventricular remodelling following myocardial infarction via upregulation of microRNA-17.

  2019cites this paper
• Mean Platelet Volume – Predictor of Impending Diabetic Vascular Complications

  2019cites this paper
• Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis

  2018cites this paper
• Diabetes and number of years of life lost with and without cardiovascular disease: a multi-state homogeneous semi-Markov model

  2018cites this paper
• Circulating Micro - RNAs in Diabetic Patients: What Meaning? Short Review

  2018cites this paper
• Tip 1 ve Tip 2 Diyabet ile İlişkili miRNA'lar

  2018cites this paper
• The effects of microRNAs in activating neovascularization pathways in diabetic retinopathy

  2018cites this paper
• Endothelial dysfunction in diabetes and hypertension: Role of microRNAs and long non‐coding RNAs

  2018cites this paper
• Epigenetics Variation and Pathogenesis in Diabetes

  2018cites this paper
• Association of Elevated Urinary miR-126, miR-155, and miR-29b with Diabetic Kidney Disease.

  2018cites this paper
• Expression of miR-155, miR-146a, and miR-326 in T1D patients from Chile: relationship with autoimmunity and inflammatory markers

  2018cites this paper
• MicroRNA and Microvascular Complications of Diabetes

  2018cites this paper
• MicroRNA, Proteins, and Metabolites as Novel Biomarkers for Prediabetes, Diabetes, and Related Complications

  2018cites this paper
• Epigenetic Contribution to the Development and Progression of Vascular Diabetic Complications

  2018cites this paper
• Identification of megakaryocytes as a target of advanced glycation end products in diabetic complications in bone marrow

  2018cites this paper
• Biomarkers of diabetic kidney disease

  2018cites this paper
• MicroRNAs in type 1 diabetes: new research progress and potential directions.

  2018cites this paper
• Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging?

  2017cites this paper
• Decoding Noncoding RNAs: Role of MicroRNAs and Long Noncoding RNAs in Ocular Neovascularization

  2017cites this paper
• Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes

  2017cites this paper
• Insights into the Diagnostic Potential of Extracellular Vesicles and Their miRNA Signature from Liquid Biopsy as Early Biomarkers of Diabetic Micro/Macrovascular Complications

  2017cites this paper
• Epigenetics of kidney disease

  2017cites this paper
• Endothelial miRNAs as Cellular Messengers in Cardiometabolic Diseases.

  2017cites this paper
• Roles of miRNAs and long noncoding RNAs in the progression of diabetic retinopathy

  2017cites this paper
• Omics Biomarkers in Ophthalmology.

  2017cites this paper
• Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy

  2017cites this paper
• Epigenetic regulation of redox signaling in diabetic retinopathy: Role of Nrf2

  2017cites this paper
• TBC update: personalized epigenetic management of diabetes.

  2017cites this paper
• BIOMARKERS, GENOMICS, PROTEOMICS, AND GENE

  year unknowncites this paper